Intellectual property problems of biodiversity in multi-dimensional perspective

Abstract

The characteristic of biodiversity is the country or national ownership of biodiversity resources, while intellectual property protects private interest and emphasizes privatization. The conflict between them directly results in the weak protection of biodiversity; as a result, many economic benefit disputes generates between the developed countries and the developing countries. Therefore, coordinating the correlation between biodiversity and intellectual property becomes especially important. Though the Convention on Biological Diversity (CBD), Trade Related Aspects Intellectual Property Rights (TRIPS) and International Union for the Protection of New Varieties of Plants (UPOV) convention have made stipulations, the complete coordination is still difficult to be realized due to the limitations. Biodiversity is impossible to be the object of intellectual property, but biotechnological products or traditional knowledge produced because of the application of biodiversity can be the direction of intellectual property protection. China which is a great power in aspects of biodiversity resources and biotech cutting-edge technology not only has to keep the biodiversity of China away from infringement, but also needs to positively involve in intellectual property laws formulation and international corporation, maintaining the common interests of the developing countries, and make contributions to the intellectual property protection of biodiversity.

https://doi.org/10.5912/jcb804
Requires Subscription or Fee PDF

Unless specified by prior arrangement, the author agrees to the following terms and assurances:

  1. For myself and on behalf of the other authors listed on this work, I assign to thinkBiotech LLC the copyright* in the contribution for the full term throughout the world.
  2. I/we further give to the following assurances
    1. I am the sole author of the contribution, or, if not, I have the written authority of the other authors to transfer the copyright* to thinkBiotech LLC and give these warranties;
    2. I and (where appropriate) the other authors are entitled to transfer the copyright to thinkBiotech LLC and no one else would be entitled to prevent us from publishing the contribution;
    3. To the best of my/our knowledge, all the facts in the contribution are true and accurate;
    4. The content of the contribution is entirely original to me (and where appropriate to the other authors) or, if not, the written permission of the owner of the copyright in any material copied from elsewhere has been obtained for all media (all such permissions to be attached to the contribution as supplementary files);
    5. Nothing in the contribution is obscene or libellous;
    6. Nothing in the contribution infringes any duty of confidentiality which I/or the other authors may owe to anyone else.
    7. I and/or the other authors have obtained the appropriate clearances from my/our employer(s) or other concerned institution(s).
* Works by US government employees prepared as part of official duties are in the public domain and the authors are therefore exempt from copyright assignment.